Is triple antithrombotic therapy, or rather its duration and composition, the true culprit for the excess of bleeding events observed in patients with atrial fibrillation undergoing coronary intervention?-Reference-Cited by-同舟云学术

Is triple antithrombotic therapy, or rather its duration and composition, the true culprit for the excess of bleeding events observed in patients with atrial fibrillation undergoing coronary intervention?

Published:2018-11-05 Issue:2 Volume:40 Page:216-217
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Gragnano Felice¹,Calabrò Paolo²³,Valgimigli Marco¹

Affiliation:

1. Department of Cardiology, Bern University Hospital, University of Bern, Freiburgstrasse 8, Bern, Switzerland

2. Division of Clinical Cardiology, A.O.R.N. Sant'Anna e San Sebastiano, F. Palasciano, Caserta, Italy

3. Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, P.zza L. Miraglia 2, Naples, Italy

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/40/2/216/27397867/ehy675.pdf

Reference3 articles.

1. Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials;Golwala;Eur Heart J,2018

2. Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial;Valgimigli;Eur Heart J,2017

3. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS);Valgimigli;Eur Heart J,2018

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical implications of combination proton pump inhibitor and triple therapies in patients with atrial fibrillation following percutaneous intervention: a guide for clinicians;Expert Review of Cardiovascular Therapy;2024-09-12

2. Ticagrelor monotherapy after acute coronary syndrome: lessons from the ULTIMATE-DAPT trial;Future Cardiology;2024-08-12

3. Comparative safety review of antithrombotic treatment options for patients with atrial fibrillation undergoing percutaneous coronary intervention;Expert Opinion on Drug Safety;2024-01-17

4. Antithrombotic Therapy Optimization in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention;Journal of Clinical Medicine;2023-12-23

5. Impact of using risk scores to guide clinical decisions: Do they make a difference?;International Journal of Cardiology;2023-10